Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation

PHASE4CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

July 27, 2019

Study Completion Date

August 12, 2019

Conditions
Atrial FibrillationEnd Stage Renal Disease
Interventions
DRUG

apixaban

oral anticoagulant

DRUG

warfarin

oral anticoagulant

Trial Locations (58)

12601

Advanced Kidney Care of Hudson Valley, Poughkeepsie

17033

Penn State Health - Milton S. Hershey Medical Center, Hershey

18017

Northeast Clinical Research Ctr, Bethlehem

20010

Washington Nephrology Associates, Washington D.C.

20912

Washington Nephrology Associates, Takoma Park

21224

The Johns Hopkins University, Baltimore

21401

Anne Arundel Medical Center, Annapolis

22304

Washington Nephrology Associates, Alexandria

22908

University of Virgina Health System, Charlottesville

23606

TPMG Clinical Research, Newport News

24014

Valley Nephrology Associates, Roanoke

24701

Nephrology and Hypertension Associates, Bluefield

26506

West Virginia University, Morgantown

27704

Durham Nephrology Associates, Durham

27834

East Carolina University, Greenville

28504

Eastern Nephrology Associates, PLLC., Kinston

28562

Eastern Nephrology Associates, PLLC, New Bern

29118

South Carolina Nephrology and Hypertension, Orangeburg

29150

Sumter Medical Specialists, Sumter

29203

Columbia Nephrology Associates, Columbia

33071

South Florida Nephrology Group PA, Research Division, Coral Springs

33126

LG. Diagnostic, Inc. & Cosmetic Center, Miami

33144

Nuren Medical and Research Center, Miami

33165

Medical Professional Clinical Research Center, Miami

35805

Nephrology Consultants, Huntsville

37923

Knoxville Kidney Center, Knoxville

38801

Nephrology & Hypertension Associates, Tupelo

39501

Southern Clinical Research Group, LLC, Gulfport

39601

Southwest Mississippi Nephrology, PLLC, Brookhaven

43215

HNC Dialysis, Ltd., Columbus

46804

NANI Research, Fort Wayne

48060

St. Clair Nephrology, Port Huron

49007

Paragon Health Neprhology Centre, Kalamazoo

54401

Aspirius Research Institute, Wausau

55905

Mayo Clinic, Rochester

57701

Regional Health Clinical Research, Rapid City

60014

NANI Research, Crystal Lake

60305

NANI Research, River Forest

60611

Northwestern University, Chicago

63136

Polack Renal, LLC, St Louis

71101

Northwest Louisiana Nephrology, Shreveport

77099

Southwest Houston Research, Ltd., Houston

79416

Lubbock Vascular Access Center, Lubbock

83642

Boise Kidney and Hypertension Institute, Meridian

84112

University of Utah, Salt Lake City

87109

Renal Medicine Associates, Albuquerque

89511

Sierra Nevada Nephrology Consultants, Reno

90806

DaVita Clinical Trials, LLC, Long Beach

Southland Renal Medical Group, Long Beach

91324

Valley Renal Medical Group Research, Northridge

93720

The Medical Research Group, Inc., Fresno

95126

Satellite Healthcare, San Jose

95661

Summit Nephrology Medical Group, Inc., Roseville

98104

University of Washington, Seattle

02114

Massachusetts General Hospital, Boston

02360

South Shore Nephrology, Plymouth

01107

Renal and Transplant Associates of New England, Springfield

02903

Rhode Island Hospital, Providence

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Christopher Granger, MD

OTHER